1. Hormonal Contraception and the Risk of Breast Cancer in Women of Reproductive Age: A Meta-Analysis
   Luz Angela Torres-de la Roche et al, 2023, Cancers CrossRef
2. Breast cancer risk of hormonal contraception: Counselling considering new evidence
   Lino Del Pup et al, 2019, Critical Reviews in Oncology/Hematology CrossRef
3. Association of Use of the Oral Contraceptive Pill (OCP) with the Expression Pattern of Different Molecular Subtypes of Breast Cancer
   Vitthal Khode et al, 2022, Current Women s Health Reviews CrossRef
4. Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits
   Lieske H Schrijver et al, 2022, JNCI: Journal of the National Cancer Institute CrossRef
5. Recent Use of Oral Contraceptives and Risk of Luminal B, Triple-Negative, and HER2-Overexpressing Breast Cancer
   Nicole C. Lorona et al, 2019, Hormones and Cancer CrossRef
6. Oral Contraceptive Use and Breast Cancer Risk According to Molecular Subtypes Status: A Systematic Review and Meta-Analysis of Case-Control Studies
   Agnieszka Barańska et al, 2022, Cancers CrossRef
7. Main risk factors for breast cancer and proposals for its prevention
   S. M. Portnoy, 2018, Tumors of female reproductive system CrossRef
8. Epidemiology of Triple-Negative Breast Cancer
   Frederick M. Howard et al, 2021, The Cancer Journal CrossRef
9. Insights into the Behavior of Triple-Negative MDA-MB-231 Breast Carcinoma Cells Following the Treatment with 17β-Ethinylestradiol and Levonorgestrel
   Sebastian Simu et al, 2021, Molecules CrossRef
10. Oral contraceptives and breast cancer risk: An overestimated risk?
    Gianluca Franceschini et al, 2020, Critical Reviews in Oncology/Hematology CrossRef
11. Triple Negative Breast Cancer: A Mountain Yet to Be Scaled Despite the Triumphs
    Qitong Wu et al, 2021, Cancers CrossRef
12. Omega-3 supplementation in the treatment of polycystic ovary syndrome (PCOS) – a review of clinical trials and cohort
    Vitoria Melo et al, 2022, Endocrine Regulations CrossRef
13. Lifestyle Changes and Prevention: Unique Issues for Young Women
    Nathalie Levasseur et al, 2020, Breast Cancer in Young Women CrossRef
14. Fat Biology in Triple-Negative Breast Cancer: Immune Regulation, Fibrosis, and Senescence
    Chae Min Lee et al, 2023, Journal of Obesity & Metabolic Syndrome CrossRef
15. HIF-2α regulates CD44 to promote cancer stem cell activation in triple-negative breast cancer via PI3K/AKT/mTOR signaling
    Jie Bai et al, 2020, World Journal of Stem Cells CrossRef
16. Epidemiology beyond its limits
    Lauren E. McCullough et al, 2022, Science Advances CrossRef
17. Breast cancer screening in young women
    Ya. I. Kochetkova et al, 2023, Tumors of female reproductive system CrossRef
18. Effect of age at first use of oral contraceptives on breast cancer risk
    Li-Wei Ji et al, 2019, Medicine CrossRef
19. Risk factors for breast cancer subtypes among Black women undergoing screening mammography
    Tara M. Friebel-Klingner et al, 2021, Breast Cancer Research and Treatment CrossRef
20. Oral contraceptives and risk of breast cancer and ovarian cancer in women with a BRCA1 or BRCA2 mutation: a meta-analysis of observational studies
    Junli Park et al, 2022, Carcinogenesis CrossRef
21. Oral Contraceptive Use and Assessment of Breast Cancer Risk among Premenopausal Women via Molecular Characteristics: Systematic Review with Meta-Analysis
    Agnieszka Barańska, 2022, International Journal of Environmental Research and Public Health CrossRef